ArticleScientific reports2020
Fungal Cell Wall and Methyl-β-Cyclodextrin Synergistically Enhance Paclitaxel Biosynthesis and Secretion in Corylus avellana Cell Suspension Culture.
Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 40 citations in OpenAlex.
- Piriformospora indica culture filtrate and cell extract induce chicoric acid production in Echinacea purpurea hairy roots.PloS one · 2025Article
- Inducing Effect of Corylus avellana on Cytotoxic Activity in Lung and Breast Cancer Cells via Apoptosis.Plant foods for human nutrition (Dordrecht, Netherlands) · 2024Article
- The Impact of Cyclodextrins on the Physiology ofMolecules (Basel, Switzerland) · 2024Article
- Biocontrol of Diplodia bulgarica, the causal agent of apple canker, using Trichoderma zelobreve.Archives of microbiology · 2024Article
- Eco-friendly approaches to phytochemical production: elicitation and beyond.Natural products and bioprospecting · 2024Review
- Culture-based diversity of endophytic fungi of three species ofFrontiers in microbiology · 2024Article
- Transcriptomics and Physiological Analyses Reveal Changes in Paclitaxel Production and Physiological Properties inPlants (Basel, Switzerland) · 2023Article
- Research Advances in Clinical Applications, Anticancer Mechanism, Total Chemical Synthesis, Semi-Synthesis and Biosynthesis of Paclitaxel.Molecules (Basel, Switzerland) · 2023Review
- Biosynthesis of anticancer phytochemical compounds and their chemistry.Frontiers in pharmacology · 2023Review
- Biotechnology and In Vitro Culture as an Alternative System for Secondary Metabolite Production.Molecules (Basel, Switzerland) · 2022Review
- Production of bioactive plant secondary metabolites through in vitro technologies-status and outlook.Applied microbiology and biotechnology · 2021Review
- Whole fungal elicitors boost paclitaxel biosynthesis induction in Corylus avellana cell culture.PloS one · 2020Article
- Article
- Mathematical Modeling of Growth and Paclitaxel Biosynthesis inFrontiers in plant science · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paclitaxel is the top-selling chemotherapeutic drug used for the treatment of lung, ovarian and breast cancer as well as Kaposi's sarcoma. Cell suspension culture (CSC) of Corylus avellana has been addressed as a promising alternative for producing paclitaxel. In this study, endophytic fungus strain YEF
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.